Welcome
Support Centre
03 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The management of anxiety in Alzheimer's disease - A pilot study of a single-blind randomised controlled trial using an intervention package with a three month follow-up
ISRCTN ISRCTN33534489
ClinicalTrials.gov identifier
Public title The management of anxiety in Alzheimer's disease - A pilot study of a single-blind randomised controlled trial using an intervention package with a three month follow-up
Scientific title
Acronym N/A
Serial number at source N0577167824
Study hypothesis Does the management of anxiety in Alzheimer's disease result in a significant reduction in anxiety, improved QoL and an improvement in carer mental health?
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Nervous System Diseases: Alzeihmer's disease
Participants - inclusion criteria Participants will be selected from 5 centres within North East London Mental Health Trust.
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/11/2005
Anticipated end date 01/08/2006
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions 1. Systematic review of evidence.
2. Recruiting participants through day centres, lunch clubs with specialist provision for dementia.
3. Randomisation of participants.
4. Intervention package, which will involve a stepped care plan using physical, drug, social and psychological interventions.
5. Follow-up, which will be done 3 months post intervention.
6. Data-Analysis will be done on an intent to treat basis and will be achieved by using analysis of co-variance.
Primary outcome measure(s) Rating of Anxiety in Dementia (RAID), QoL-AD and the General Health Questionnaire (GHQ-12)
Secondary outcome measure(s) Not provided at time of registration
Sources of funding North East London Mental Health NHS Trust (UK)

Trial website
Publications
Contact name Dr  Afifa  Qazi
  Address Old Age Psychiatry
Mascalls Park Hospital
Mascalls Lane
  City/town Brentwood
  Zip/Postcode CM15 5HQ
  Country United Kingdom
  Tel +44 01277 302736
  Fax +44
  Email afifaqazi@hotmail.com
Sponsor Record Provided by the NHSTCT Register - 2006 Update - Department of Health (UK)
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 29/09/2006
Last edited 19/02/2008
Date ISRCTN assigned 29/09/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central